跳至主要内容
临床试验/JPRN-UMIN000053550
JPRN-UMIN000053550已完成Unknown

A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer. - A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.

iigata University Medical and Dental Hospital0 个研究点目标入组 165 人开始时间: 2024年2月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) FDG uptake on lung region was difficult to evaluate owing to massive consolidation or pleural effusion (2) Patients with bilateral multiple primary lung cancers.

研究者

发起方
iigata University Medical and Dental Hospital

相似试验

已完成
不适用
Evaluation of 18F-FDG-PET/CT in the diagnosis and treatment response of bone metastasis.bone metastasis
JPRN-UMIN000005866ational Cancer Center Research Projects Management expenses Grants from the Government to National Cancer Research Center220
进行中(未招募)
1 期
Study to see if new research scans can show how treatment affects the blood supply to kidney cancersPrimary and metastatic cancer. The active substance is a diagnostic agent that identifies angiogenesis associated with tumour growth.MedDRA version: 14.1 Level: PT Classification code 10050018 Term: Renal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10038389 Term: Renal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-002833-20-GBOxford University Hospitals NHS Trust10
已完成
不适用
Early response evaluation with 18F-FDG PET/CT and immunological profiling of circulating immune cells and tumor-draining lymph nodes in non-small cell lung cancer patients treated with immunotherapy.lung cancer
NL-OMON48669Antoni van Leeuwenhoek Ziekenhuis50
已完成
不适用
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.ovarian cancer
NL-OMON29961Academisch Ziekenhuis Maastricht20
已完成
不适用
[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseases
JPRN-UMIN000023101Tokyo Medical and Dental University40